Youth are not just leaders of tomorrow – they are changemakers, capable of inspiring one another and driving impactful change ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

The World Health Organization (WHO) has validated Senegal as having eliminated trachoma as a public health problem. Senegal ...

As science soars with game-changing HIV tools, a funding crisis threatens to ground progress "We come together at a pivotal ...

A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

"While an HIV vaccine remains elusive, lenacapavir is the next best thing: a long-acting antiretroviral shown in trials to prevent almost all HIV infections among those at risk," said Dr Tedros ...

The World Health Organization (WHO) has validated Senegal as having eliminated trachoma as a public health problem. Senegal ...

In 2024, 89% of infants globally – about 115 million – received at least one dose of the diphtheria, tetanus and pertussis ...

An estimated 14.3 million children globally remain unvaccinated and vulnerable to vaccine-preventable illnesses – meaning ...

The recognition came just weeks after the Seventy-eighth World Health Assembly approved the Agreement in May 2025, marking ...

Trachoma, a bacterial eye infection caused by Chlamydia trachomatis, remains the leading infectious cause of blindness ...